Brief: Sensorion Announces EUR 20 MLN Convertible Bond Issue

Sensorion SA

12/06/2019 06:34

June 12 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION ANNOUNCES A €20M CONVERTIBLE BOND ISSUE SUBSCRIBED BY TWO
RENOWNED
INVESTORS INVUS AND SOFINNOVA PARTNERS
    * BONDS WILL BE MANDATORILY CONVERTED INTO SHARES ON MATURITY DATE (JUNE 13
2024)
    * FUNDS RAISED WILL ALLOW TO CONTINUE CLINICAL DEVELOPMENT OF PHASE 2
PROGRAMS FOR
SENS-111 AND SENS-401
    * FUNDS RAISED WILL ALLOW TO INITIATE NEW GENE THERAPY PROGRAMS IN INNER EAR
DISEASES
    * EUR 20M ISSUE OF BONDS MANDATORILY CONVERTIBLE INTO ORDINARY SHARES OF
COMPANY
SUBSCRIBED BY INVUS PUBLIC EQUITIES LP AND SOFINNOVA CROSSOVER I SLP, WHICH
BECOME LONG-TERM PARTNERS FOR SENSORION'S TRANSFORMATION
    * WE EXPECT THE RESULTS OF THE PHASE 2 TRIAL ON THE EFFICACY OF SENS-111 IN
ACUTE
UNILATERAL VESTIBULOPATHY IN THE SECOND HALF OF 2019
    * ENTERED INTO A SUBSCRIPTION AGREEMENT WITH INVUS PUBLIC EQUITIES LP AND
SOFINNOVA CROSSOVER I SLP AS SUBSCRIBERS TO BONDS CONVERTIBLE INTO COMMON SHARES
FOR EUR 12.5 MILLION AND EUR 7.5 MILLION, RESPECTIVELY

Source text for Eikon:  ID:nBw83Kwfra 
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))